ADC Therapeutics SA (ADCT) stock
ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.34−0.07 (-4.96%)
Close on Nov 13, 2026Market cap $171.08MP/E –Yield –
ADC Therapeutics statistics
79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 9, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- -0.12
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 32.9%
- 10.8%
- Shares Change (QoQ)
- 0.24%
- 0.50%
- Float
- 73M
- 49M
- Shares Held by Insiders
- 42.8%
- 11.7%
- Shares Held by Institutions
- 72.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 6M
- –
- Short Interest Change
- 1.39%
- -0.80%
- Short % of Float
- 8.80%
- 9.01%
- Short % of Shares Outstanding
- 5.03%
- 6.30%
- Days to Cover
- 6.66
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $4.98
- –
- 52-Week Low
- $0.78
- –
- 20-Day Moving Average
- $1.54
- –
- 50-Day Moving Average
- $1.39
- –
- 200-Day Moving Average
- $2.38
- –
- Average True Range (14)
- $0.17
- –
- Price Change (1 Week)
- -15.2%
- -1.15%
- Price Change (1 Month)
- -10.1%
- -4.87%
- Price Change (3 Months)
- 21.8%
- -21.0%
- Price Change (6 Months)
- -58.8%
- -20.6%
- Price Change (YTD)
- -62.0%
- -23.6%
- Price Change (1 Year)
- -66.9%
- -22.4%
- Price Change (3 Years)
- 143.2%
- -29.5%
- Price Change (5 Years)
- -94.9%
- -77.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.75
- 0.70
- Relative Strength Index (14)
- 43.4
- 43.4
- Volatility (1 Year)
- 99.6%
- 80.1%
- Beta (5 Years)
- 1.95
- 1.07
MarginsIndustry
- Pretax Margin
- -96.2%
- -11.6%
- EBITDA Margin
- -97.7%
- -27.7%
- FCF Margin
- -118.5%
- -9.56%
Returns on capitalIndustry
- Return on Assets (ROA)
- -29.8%
- -40.6%
- Return on Capital Employed (ROCE)
- -46.7%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.05
- 3.30
- Quick Ratio
- 2.42
- 2.39
- Interest Coverage
- -1.58
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 12.8%
- 6.82%
- Revenue Growth (3Y CAGR)
- -27.1%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.31
- 0.40
- Revenue Per Employee
- $451.45K
- $429.29K
- Profits Per Employee
- -$432.16K
- -$689.41K
- Employee Count
- 188
- 74
- WACC
- 14.7%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$81.65M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $181.40M
- $17.76M
- Net Cash Per Share
- $1.42
- $0.80
- Equity (Book Value)
- -$249.17M
- $53.89M
- Book Value Per Share
- -$1.95
- $1.50
- Tangible Book Value
- -$249.17M
- $27.13M
- Working Capital
- $160.45M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$32.00K
- -$1.00M
- FCF Per Share
- -$0.79
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -47.5%
- -21.8%
- FCF Yield
- -58.8%
- -9.44%
- Buyback Yield
- -25.0%
- -0.76%
- Shareholder Yield
- -25.0%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $52.60M
- $2.90M
- Income Tax
- -$404.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -9.14
- 0.23
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ADCT | S&P 500 | Difference | ADCT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -21.2% | -3.0% | −18.1 pts | ||
| 3 months | +27.6% | -2.8% | +30.4 pts | ||
| Year to date | -62.0% | +11.5% | −73.5 pts | ||
| 1 year | -66.9% | +13.5% | −80.4 pts | ||
| 3 years | +168.0% | +77.7% | +90.3 pts | +38.9% | +21.1% |
| 5 years | -94.9% | +72.6% | −167.5 pts | -44.9% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
6M ADCT shares were sold short on Oct 30, 2026, up 1.4% from the previous report, or 8.80% of the shares available to trade. At recent volumes it would take 6.7 days to buy them back. Over the last 20 sessions, 46.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 6,427,616 | +1.4% | 964,848 | 6.7 |
| Oct 15, 2026 | 6,339,655 | -8.1% | 2,156,876 | 2.9 |
| Sep 30, 2026 | 6,896,051 | +27.9% | 1,579,045 | 4.4 |
| Sep 15, 2026 | 5,390,567 | -14.2% | 1,401,300 | 3.9 |
| Aug 31, 2026 | 6,285,964 | +1.8% | 2,212,555 | 2.8 |
| Aug 14, 2026 | 6,175,703 | +21.3% | 979,767 | 6.3 |
| Jul 31, 2026 | 5,092,137 | -8.0% | 834,025 | 6.1 |
| Jul 15, 2026 | 5,534,142 | -7.7% | 1,379,837 | 4.0 |
| Jun 30, 2026 | 5,993,673 | -0.2% | 1,763,741 | 3.4 |
| Jun 15, 2026 | 6,004,943 | -1.0% | 4,781,581 | 1.3 |
| May 29, 2026 | 6,067,857 | +5.6% | 781,868 | 7.8 |
| May 15, 2026 | 5,747,020 | +5.0% | 1,455,366 | 4.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?